Publications

Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.

Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.

See below for some of our recent publications.

MindMotion GO (MindMaze) for Stroke Telerehabilitation

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of MindMotion GO (MindMaze) for stroke telerehabilitation to improve motor function.

Rethymic (Enzyvant Therapeutics Inc.) for Congenital Athymia

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Rethymic (Enzyvant Therapeutics Inc.) for increased longevity and immune reconstitution in pediatric patients with congenital athymia.

Luminopia One for Amblyopia in Children

The Luminopia One is a software-only digital therapeutic used with commercially available head-mounted displays intended for home use for improvement in visual acuity in amblyopia patients aged 4-7 years associated with anisometropia and/or with mild strabismus, having received treatment instructions (frequency and duration) as prescribed by a trained eye care professional.

DecisionDx-Melanoma

This report evaluates the analytical validity, clinical validity, and clinical utility of the DecisionDx-Melanoma test.